AU Patent

AU2007292347A1 — Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist and/or antagonist biological activity

Assigned to Allergan Inc · Expires 2008-03-13 · 18y expired

What this patent protects

Patent listed against Velsipity.

Drugs covered by this patent

Velsipity (Etrasimod Arginine) · Pfizer Inc.

Patent Metadata

Patent number: AU2007292347A1
Jurisdiction: AU
Classification: —
Expires: 2008-03-13
Drug substance claim: No
Drug product claim: No
Assignee: Allergan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.